CAD 0.02
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -2.17 Million CAD | -184.42% |
2022 | -764 Thousand CAD | -174.68% |
2021 | 1.02 Million CAD | 145.09% |
2020 | -2.26 Million CAD | -149.68% |
2019 | 4.56 Million CAD | 122.77% |
2018 | -20.06 Million CAD | 64.71% |
2017 | -56.84 Million CAD | -299.02% |
2016 | -14.24 Million CAD | -29673.5% |
2015 | -47.84 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q4 | -2.17 Million CAD | -57.01% |
2023 Q3 | -1.38 Million CAD | -27.68% |
2023 Q2 | -1.08 Million CAD | -15.69% |
2023 Q1 | -937 Thousand CAD | -22.64% |
2022 Q1 | 627 Thousand CAD | -38.71% |
2022 Q4 | -764 Thousand CAD | 24.95% |
2022 Q3 | -1.01 Million CAD | 45.47% |
2022 Q2 | -1.86 Million CAD | -397.77% |
2021 Q1 | -2.14 Million CAD | 0.0% |
2021 Q4 | 1.02 Million CAD | 126.83% |
2021 Q3 | 451 Thousand CAD | 431.62% |
2021 Q2 | -136 Thousand CAD | 93.65% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 4.89 Million CAD | 144.405% |
CanadaBis Capital Inc. | 4.08 Million CAD | 153.206% |
Decibel Cannabis Company Inc. | 37.48 Million CAD | 105.797% |
Entourage Health Corp. | 150.32 Million CAD | 101.446% |
Lifeist Wellness Inc. | -188.12 Thousand CAD | -1055.058% |
Cannara Biotech Inc. | 41.51 Million CAD | 105.235% |
Medicure Inc. | -5.82 Million CAD | 62.695% |
PharmaCielo Ltd. | 18.24 Million CAD | 111.909% |
Rubicon Organics Inc. | 475.37 Thousand CAD | 557.116% |
BioSyent Inc. | -3.68 Million CAD | 41.031% |
Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | 5831.241% |